Management of metastatic disease from neuroendocrine cancers
Gupta, S, Yao, J, Ahrar, K, et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the MD Anderson experience. Cancer J 2003; 9:261.
King, J, Quinn, R, Glenn, DM, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113:921.
Kulke, MH, Hornick, JL, Frauenhoffer, C, et al. O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Clin Cancer Res 2009; 15:338.
Kwekkeboom DJde Herder W, Kam B, et al. Treatment with the radiolabeled aomatostatin analog [177 Lu-DOTA 0, Tyr3] octreotate: toxicity, efficacy, and survival. Journal of Clinical Oncology 2008; 26:2124-2130.
LeTreut Y, Gregoire E, Belghiti J, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. American Journal of Transplantation 2008; 8: 1205-1213.
Musunuru, S, Chen, H, Rajpal, S, et al. Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg 2006; 141:1000.
Rinke, A, Muller, HH, Schade-Brittinger, C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009; 27:4656.
Rhee, TK, Lewandowski, RJ, Liu, DM, et al. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 2008; 247:1029.
Sarmiento, JM, Heywood, G, Rubin, J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197:29.
Siperstein, AE, Berber, E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001; 25:693.